Home › Companies › Anika Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Anika Therapeutics, Inc.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 18, 2026: 7 items on Anika Therapeutics, Inc.’s Form 8-K, filed June 23, 2026: 3 approved · 4 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Anika Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Anika Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Gary P. Fischetti | 9,248,053 | 117,967 | 27,781 | -- | 1,801,866 | 99% | Not verified | — |
| Elect Director: John B. Henneman, III | 8,829,035 | 536,988 | 27,778 | -- | 1,801,866 | 94% | Not verified | — |
| Elect Director: Stephen D. Griffin | 9,309,707 | 56,276 | 27,818 | -- | 1,801,866 | 99.3% | Not verified | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 11,136,590 | 24,966 | 34,111 | -- | 0 | 99.7% | Approved | — |
| 3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and | 8,268,676 | 1,093,946 | 31,179 | -- | 1,801,866 | 88% | Not verified | — |
| 4. The Revised Seventh Amended Plan, increasing the number of shares of common stock reserved thereunder from 5,760,000 to 6,110,000 | 8,013,994 | 1,347,970 | 31,837 | -- | 1,801,866 | 86% | Approved | — |
| 5. The amendment of the ESPP, increasing the number of shares of common stock reserved thereunder from 200,000 to 400,000 | 9,110,892 | 257,394 | 25,515 | -- | 1,801,866 | 97% | Approved | — |
Source: Anika Therapeutics, Inc., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.
Each item below shows how the 166 asset managers that disclosed a Anika Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Anika Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors: Gary P. Fischetti
Anika Therapeutics, Inc.’s own tally for this item (“Elect Director: Gary P. Fischetti”): 9,248,053 for, 117,967 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 2,291,950 for, 17,981 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 669,373 | 0 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 135,437 | 0 | 0 | 0 | For |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 18,979 | 13,200 | 0 | 0 | Mixed |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors: John B. Henneman, III
Anika Therapeutics, Inc.’s own tally for this item (“Elect Director: John B. Henneman, III”): 8,829,035 for, 536,988 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 2,269,670 for, 40,261 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 667,688 | 1,685 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 135,437 | 0 | 0 | 0 | For |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 18,979 | 13,200 | 0 | 0 | Mixed |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,986 | 9,395 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 9,845 | 0 | 0 | Against |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III Directors: Stephen D. Griffin
Anika Therapeutics, Inc.’s own tally for this item (“Elect Director: Stephen D. Griffin”): 9,309,707 for, 56,276 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 2,309,931 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 669,373 | 0 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 135,437 | 0 | 0 | 0 | For |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 32,179 | 0 | 0 | 0 | For |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 2 wordings of this item as funds reported it.
86% of fund votes cast · no official result
The 50 asset managers below reported 1,975,586 for, 330,696 against, 3,649 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 668,237 | 1,136 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 0 | 155,228 | 0 | 0 | Against |
| American Century | 0 | 135,437 | 0 | 0 | Against |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 32,179 | 0 | 0 | 0 | For |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 18,583 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,986 | 9,395 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 3 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: Approval of the Amendment of the Anika Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Anika Therapeutics, Inc.’s own tally for this item (“4. The Revised Seventh Amended Plan, increasing the number of shares of common stock reserved thereunder from 5,760,000 to 6,110,000”): 8,013,994 for, 1,347,970 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 4 Stockholders approved the Revised Seventh Amended Plan, increasing the number of shares of common stock reserved thereunder from 5,760,000 to 6,110,000.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 2,309,930 for, 1 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 669,372 | 1 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 135,437 | 0 | 0 | 0 | For |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 32,179 | 0 | 0 | 0 | For |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Anika Therapeutics, Inc.’s own tally for this item (“3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussi”): 8,268,676 for, 1,093,946 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 669,371 | 2 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 0 | 135,437 | 0 | 0 | Against |
| Dimensional | 0 | 120,390 | 0 | 0 | Against |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 0 | 61,927 | 0 | 0 | Against |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 32,179 | 0 | 0 | 0 | For |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 0 | 19,862 | 0 | 0 | Against |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 9,395 | 2,986 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 0 | 5,244 | 0 | 0 | Against |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Fund voting reports, all 50 managers: 1,952,287 for, 357,644 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Caligan Partners LP | 1,293,059 | 0 | 0 | 0 | For |
| BlackRock | 948,475 | 0 | 0 | 0 | For |
| Renaissance | 487,866 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 437,285 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,432 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 331,137 | 0 | 0 | 0 | For |
| State Street | 314,227 | 0 | 0 | 0 | For |
| DE Shaw | 233,788 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 209,757 | 0 | 0 | Against |
| AQR | 177,905 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 168,374 | 0 | 0 | 0 | For |
| Two Sigma | 163,204 | 0 | 0 | 0 | For |
| Nuveen | 155,796 | 0 | 0 | 0 | For |
| Goldman Sachs | 135,891 | 0 | 0 | 0 | For |
| American Century | 0 | 135,437 | 0 | 0 | Against |
| Charles Schwab | 114,391 | 0 | 0 | 0 | For |
| Vanguard | 95,040 | 0 | 0 | 0 | For |
| Northern Trust | 88,948 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 87,600 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 86,927 | 0 | 0 | Against |
| ENVESTNET ASSET MANAGEMENT INC | 63,201 | 0 | 0 | 0 | For |
| Dimensional | 0 | 59,907 | 0 | 0 | Against |
| Point72 | 52,553 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 45,729 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 45,620 | 0 | 0 | Against |
Institutional-manager reports, all 134 managers: 6,270,226 for, 560,217 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Anika Therapeutics, Inc.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 11,136,590 for, 24,966 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 2 Stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 2,309,931 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 669,373 | 0 | 0 | 0 | For |
| BlackRock | 425,372 | 0 | 0 | 0 | For |
| Fidelity | 302,468 | 0 | 0 | 0 | For |
| TIAA | 155,228 | 0 | 0 | 0 | For |
| American Century | 135,437 | 0 | 0 | 0 | For |
| Dimensional | 120,390 | 0 | 0 | 0 | For |
| Charles Schwab | 113,228 | 0 | 0 | 0 | For |
| MFS | 61,927 | 0 | 0 | 0 | For |
| Nationwide | 47,569 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 35,515 | 0 | 0 | 0 | For |
| Equitable | 32,179 | 0 | 0 | 0 | For |
| GuideStone | 23,888 | 0 | 0 | 0 | For |
| Invesco | 19,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,583 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 17,500 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,037 | 0 | 0 | 0 | For |
| Northern Trust | 9,845 | 0 | 0 | 0 | For |
| Thrivent | 9,199 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,681 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,535 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,397 | 0 | 0 | 0 | For |
| Global X | 5,376 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 13,357,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.01% |
| 2 | BlackRock | 3.18% |
| 3 | Fidelity | 2.26% |
| 4 | TIAA | 1.16% |
| 5 | American Century | 1.01% |
| 6 | Dimensional | 0.90% |
| 7 | Charles Schwab | 0.85% |
| 8 | MFS | 0.46% |
| 9 | Nationwide | 0.36% |
| 10 | Columbia Threadneedle | 0.27% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Caligan Partners LP | 9.68% |
| 2 | BlackRock | 7.10% |
| 3 | Renaissance | 3.65% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 3.27% |
| 5 | BOOTHBAY FUND MANAGEMENT, LLC | 2.91% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.48% |
| 7 | State Street | 2.35% |
| 8 | DE Shaw | 1.75% |
| 9 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 1.57% |
| 10 | AQR | 1.33% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 11.94% | 13F |
| Caligan Partners LP | 10.74% | 13D |
| Vanguard Group | 5.83% | 13F |
| Morgan Stanley | 5.78% | 13F |
| Renaissance Technologies | 3.76% | 13F |
| Dimensional Fund Advisors | 3.44% | 13F |
| State Street | 2.59% | 13F |
| Two Sigma | 1.77% | 13F |
| D.E. Shaw | 1.72% | 13F |
| Trigran Investments, Inc. | 1.26% | 13G |
Percentages above are of 13,357,000 shares outstanding, as reported by Anika Therapeutics, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Anika Therapeutics, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Anika Therapeutics, Inc.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 166 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,194 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 88% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Anika Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.
Anika Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.